Literature DB >> 21337592

Design evaluation and optimization for models of hepatitis C viral dynamics.

Jeremie Guedj1, Caroline Bazzoli, Avidan U Neumann, France Mentré.   

Abstract

Mathematical modeling of hepatitis C viral (HCV) kinetics is widely used for understanding viral pathogenesis and predicting treatment outcome. The standard model is based on a system of five non-linear ordinary differential equations (ODE) that describe both viral kinetics and changes in drug concentration after treatment initiation. In such complex models parameter estimation is challenging and requires frequent sampling measurements on each individual. By borrowing information between study subjects, non-linear mixed effect models can deal with sparser sampling from each individual. However, the search for optimal designs in this context has been limited by the numerical difficulty of evaluating the Fisher information matrix (FIM). Using the software PFIM, we show that a linearization of the statistical model avoids most of the computational burden, while providing a good approximation to the FIM. We then compare the precision of the parameters that can be expected using five study designs from the literature. We illustrate the usefulness of rationalizing data sampling by showing that, for a given level of precision, optimal design could reduce the total number of measurements by up 50 per cent. Our approach can be used by a statistician or a clinician aiming at designing an HCV viral kinetics study.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21337592     DOI: 10.1002/sim.4191

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  8 in total

1.  Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studies.

Authors:  Joakim Nyberg; Caroline Bazzoli; Kay Ogungbenro; Alexander Aliev; Sergei Leonov; Stephen Duffull; Andrew C Hooker; France Mentré
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

2.  Individual Bayesian Information Matrix for Predicting Estimation Error and Shrinkage of Individual Parameters Accounting for Data Below the Limit of Quantification.

Authors:  Thi Huyen Tram Nguyen; Thu Thuy Nguyen; France Mentré
Journal:  Pharm Res       Date:  2017-06-28       Impact factor: 4.200

3.  Pharmacokinetic/Pharmacodynamic predictors of clinical potency for hepatitis C virus nonnucleoside polymerase and protease inhibitors.

Authors:  Micaela B Reddy; Peter N Morcos; Sophie Le Pogam; Ying Ou; Karl Frank; Thierry Lave; Patrick Smith
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

4.  Optimal flow rate sampling designs for studies with extended exhaled nitric oxide analysis.

Authors:  Noa Molshatski; Sandrah P Eckel
Journal:  J Breath Res       Date:  2017-02-22       Impact factor: 3.262

5.  SARS-CoV-2 viral dynamics in non-human primates.

Authors:  Antonio Gonçalves; Pauline Maisonnasse; Flora Donati; Mélanie Albert; Sylvie Behillil; Vanessa Contreras; Thibaut Naninck; Romain Marlin; Caroline Solas; Andres Pizzorno; Julien Lemaitre; Nidhal Kahlaoui; Olivier Terrier; Raphael Ho Tsong Fang; Vincent Enouf; Nathalie Dereuddre-Bosquet; Angela Brisebarre; Franck Touret; Catherine Chapon; Bruno Hoen; Bruno Lina; Manuel Rosa Calatrava; Xavier de Lamballerie; France Mentré; Roger Le Grand; Sylvie van der Werf; Jérémie Guedj
Journal:  PLoS Comput Biol       Date:  2021-03-17       Impact factor: 4.475

6.  Clinical trial simulation to evaluate power to compare the antiviral effectiveness of two hepatitis C protease inhibitors using nonlinear mixed effect models: a viral kinetic approach.

Authors:  Cédric Laouénan; Jeremie Guedj; France Mentré
Journal:  BMC Med Res Methodol       Date:  2013-04-25       Impact factor: 4.615

Review 7.  HCV Kinetic Models and Their Implications in Drug Development.

Authors:  Tht Nguyen; J Guedj
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-04-17

8.  Influence of a priori Information, Designs, and Undetectable Data on Individual Parameters Estimation and Prediction of Hepatitis C Treatment Outcome.

Authors:  T H T Nguyen; J Guedj; J Yu; M Levi; F Mentré
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.